The T cells, along with antibodies, are an integral part of the human immune response against viral infections due to their ability to directly target and kill infected cells. A Singapore study has uncovered the presence ...
Jul 16, 2020
0
5069
Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins. But antibodies that recognize the virus's internal ...
Jun 24, 2022
0
154
New research published in The Lancet shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys. Moreover, the ...
Jul 7, 2018
1
1916
A new study from Lund University in Sweden on how the Pfizer-BioNTech COVID-19 vaccine affects human liver cells under experimental conditions, has been viewed more than 800,000 times in just over a week. The results have ...
Mar 10, 2022
0
159
In March, at the start of the COVID-19 pandemic, there was a consensus among health care providers and public health officials that a vaccine that provided complete immunity to SARS-CoV-2, the virus that causes COVID-19, ...
Oct 21, 2020
0
11
Vaccines are one of our greatest tools to protect against infectious diseases and the world waits with bated breath for a vaccine against coronavirus (COVID-19). The wait might be much shorter if we can hone new methods of ...
Mar 30, 2020
0
12
When scientists were developing a vaccine against COVID-19, a key worry was the potential to cause disease enhancement. It's a complication that occurs when a vaccine does the opposite of what it's intended to do and instead ...
Oct 25, 2021
0
436
The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19. Scientists ...
Aug 19, 2020
0
79
A team of researchers affiliated with multiple institutions in the U.S. and one in the U.K. has found that administering the AstraZeneca COVID-19 vaccine intranasally to infected hamsters and monkeys reduced viral loads in ...
Perhaps the most important question now about COVID-19 is the degree to which a prior infection protects from a second infection by the new coronavirus. This affects vaccine development and herd immunity and is something ...
Jun 12, 2020
0
8
